Chlorogenic Acid Market Share Driven by Demand from Supplements and Pharmaceuticals | Valuates Reports

Chlorogenic Acid Market Size
In 2024, the global market size of Chlorogenic Acid was estimated to be worth US$ 159 million and is forecast to reach approximately US$ 192 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-33J2397/Global_Chlorogenic_Acid_Market_Insights_Forecast_to_2026

The Chlorogenic Acid market is expanding steadily, supported by growing consumer interest in natural antioxidants and plant-based bioactives across health, wellness, and skincare industries. Known for its anti-inflammatory, antihypertensive, and weight management properties, chlorogenic acid continues to gain relevance in functional products-driving increases in both market size and influence over emerging market trends.

By type, green coffee bean extract (HPLC 45%-50%) holds a notable share of the market due to its widespread use in dietary supplements and weight loss formulations. This segment is characterized by strong commercial demand, especially in North America and Europe, where clean-label trends are influencing formulation choices. Among honeysuckle-derived products, honeysuckle extract with HPLC 98% is gaining traction for its purity and pharmaceutical-grade suitability, while the lower concentration variant (HPLC 5%-20%) supports moderate growth in food and cosmetic blends. Eucommia extract segments show diverse adoption patterns: mid-range concentrations (HPLC 50%-90%) are increasingly favored in supplements and therapeutic applications, whereas the high-purity variant (HPLC 98%) sees niche demand in pharmaceuticals. Lower concentrations (HPLC 5%-30%) are used in broader functional formulations. The "Other" category, including lesser-known botanical sources, is contributing incrementally to market growth through innovation-driven entries.

By application, the supplements segment dominates the market share, reflecting chlorogenic acid's core role in metabolic health, antioxidant support, and weight management. Formulations combining chlorogenic acid with other botanicals are becoming mainstream, further amplifying market growth. The pharmaceutical segment follows closely, driven by increasing research into the compound's potential in cardiovascular health and blood sugar regulation. Cosmetic applications are showing strong momentum as well, with chlorogenic acid being integrated into anti-aging, brightening, and anti-inflammatory skincare products. The "Others" segment-which includes functional beverages and wellness teas-is expanding gradually, adding diversity to overall market size.

With rising consumer preference for plant-based and science-backed ingredients, the market forecast points to continued upward growth. The Chlorogenic Acid market is expected to advance in alignment with innovation in extraction technologies, formulation versatility, and growing demand across supplements, pharmaceutical, and cosmetic industries.

Segment by Type

• Honeysuckle Extract (HPLC 5%-20%)
• Honeysuckle Extract (HPLC 98%)
• Eucommia Extract (HPLC 5%-30%)
• Eucommia Extract (HPLC 50%-90%)
• Eucommia Extract (HPLC 98%)
• Green Coffee Bean Extract (HPLC 45%-50%)
• Other

Segment by Application

• Supplements
• Pharmaceuticals
• Cosmetics
• Others

By Company

Naturex, EUROMED SA, Applied Food Sciences, Sabinsa Corporation, Nanjing Zelang, Zhejiang Skyherb, Indfrag, Cymbio Pharma, Changsha E.K HERB, Nutragreen Biotechnology, Changsha Nulant Chem Co., Ltd, Changsha Staherb Natural Ingredients, Xi'an Hao-xuan Bio-tech Co., Ltd, FLAVOUR TROVE, Chenguang Biotech

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-33J2397/global-chlorogenic-acid

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.